Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 34Thoracic 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 1043Lung Neoplasms 800Small Cell Lung Carcinoma 193Breast Neoplasms 158Colorectal Neoplasms 156Neoplasms 128Melanoma 116Ovarian Neoplasms 111Pancreatic Neoplasms 106Stomach Neoplasms 95Neoplasm Metastasis 88Esophageal Neoplasms 77Squamous Cell Carcinoma of Head and Neck 75Prostatic Neoplasms 66Uterine Cervical Neoplasms 65Head and Neck Neoplasms 65Endometrial Neoplasms 61Triple Negative Breast Neoplasms 59Carcinoma, Renal Cell 58Colonic Neoplasms 57Mesothelioma, Malignant 48Adenocarcinoma of Lung 48Urinary Bladder Neoplasms 47Carcinoma, Hepatocellular 46Mesothelioma 42Sarcoma 40Brain Neoplasms 40Liver Neoplasms 38Disease 34NSCLC 33

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × HER2-positive Breast Cancer × Thoracic × Clear all
NCT05514717 2025-07-11

A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2

Mersana Therapeutics

Phase 1 Recruiting
162 enrolled
BreastGastrointestinalThoracic

HER2-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡